Teng and colleagues revealed that CypB was overexpressed in NSCLC and inhibition of CypB could suppress cell proliferation, migration, invasion, and angiogenesis via regulating the STAT3 pathway [37]. The gene discussed is PPIB; the disease is non-small cell lung carcinoma.